CHANGING THE WORLD BILLIONS OF CELLS ATA TIME
Live / Registered — Registered (as of 29 Mar 2022)
What this means for you
Registered since 29 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88320219
- Registration number
- 6687289
- Mark type
- Stylized text
- Filed
- 28 Feb 2019
- Published for opposition
- 18 Jun 2019
- Registered
- 29 Mar 2022
- Attorney of record
- Karen Lim
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal dna for research purposes; providing a website featuring health and healthcare information related to cancer research
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing services; collection and preservation of dna for medical purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer, testing and screening; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; providing genetics assessments in the nature of genetic counseling; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes; gene analysis and sequencing and dna analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing and dna analysis and sequencing for use in cancer diagnosis and treatment
Owner
- KIADIS PHARMA NETHERLANDS B.V., AMSTERDAM, NL
- KIADIS PHARMA INTELLECTUAL PROPERTY B.V., AMSTERDAM, NL
- KIADIS PHARMA INTELLECTUAL PROPERTY B.V., AMSTERDAM, NL
- CytoSen Therapeutics, Inc., Dallas, TX, US
- CytoSen Therapeutics, Inc., Dallas, TX, US
Prosecution history
- 12 Mar 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 May 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 May 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 17 May 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 17 May 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 May 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Feb 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Feb 2022 — USE AMENDMENT FILED
- 09 Feb 2022 — SOU EXTENSION 5 GRANTED
- 02 Feb 2022 — SOU EXTENSION 5 FILED
- 09 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL